Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diffuse Intrinsic Pontine Glioma × Dasatinib × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia, Myeloid, Chronic-Phase 16 Leukemia 9 Breast Neoplasms 9 Prostatic Neoplasms 8 Neoplasm Metastasis 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Recurrence 5 Philadelphia Chromosome 4 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Lung Neoplasms 3 Burkitt Lymphoma 3 Blast Crisis 3 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Polycythemia Vera 2 Ovarian Neoplasms 2 Neuroblastoma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Gliosarcoma 2 Glioblastoma 2 Gastrointestinal Stromal Tumors 2 Fallopian Tube Neoplasms 2

Interventions

Temozolomide 7 Radiotherapy 3 nimotuzumab 2 Everolimus 2 Erlotinib Hydrochloride 2 Cyclophosphamide 2 Bevacizumab 2 tovorafenib 1 ribociclib 1 palbociclib 1 olutasidenib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vinorelbine 1 Valproic Acid 1 Topotecan 1 TIC10 compound 1 Radiation 1 Proto-Oncogene Proteins c-akt 1 Phosphatidylinositol 3-Kinases 1 Lomustine 1 Irinotecan 1 GDC-0084 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Diphtheria-Tetanus Vaccine 1 Dasatinib 1 Cilengitide 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233049 2018-07-23

BIOMEDE

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡